Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

MitoQ helps protect hair cells from damage in hair loss by boosting a protective enzyme.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Carbon Quantum Dots can effectively detect cobalt ions and methylcobalamin in water.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

A new microneedle patch helps treat hair loss by improving drug delivery to hair follicles.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Both enzyme forms can sulfate minoxidil.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

AH-001 could be a safer and more effective treatment for hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.